January 2019 - Sperling Prostate Center

Prostatectomy is on the Decline for Low-risk Prostate Cancer

Prostate Cancer Treatment - Sperling Prostate Center

For decades, thousands of men with insignificant PCa have been overtreated with prostatectomies. A new study raises questions about the practice and sheds light on the prostatectomy's decline. keep reading

The Harsh Economics of Prostate Cancer

Over the years, I have written on various topics related to prostate health. The obvious ones include prostate cancer (PCa): how to detect, diagnose and treat it without wrecking quality of life and masculinity, nutrition, exercise, stress management, and even new drugs like metformin and rapamycin that were developed for other conditions but turn out keep reading

How to Increase the Odds for Successful Active Surveillance

Let’s start with a short quiz: What is the current preferred strategy to manage low-risk prostate cancer? a) Nerve-sparing robotic prostatectomy b) Focal treatment c) Active Surveillance d) Vitamin E, saw palmetto supplements, and avoid red meat If you answered “c) Active Surveillance,” you are correct. According to a 2017 joint guideline statement from four keep reading

Month: January 2019

Prostatectomy is on the Decline for Low-risk Prostate Cancer

The Harsh Economics of Prostate Cancer

How to Increase the Odds for Successful Active Surveillance